Delcath Systems, Inc.(DCTH)Earnings, Financials & Key Ratios

DCTH•NASDAQ

$11.24

$391M mkt cap·166.3× P/E·Price updated May 7, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryImaging, radiation, and oncology devices

AboutDelcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.Show more

Revenue$85M+129.1%
EBITDA$1M+108.3%
Net Income$3M+110.2%
EPS (Diluted)0.07+107.3%
Gross Margin86.16%+3.3%
EBITDA Margin1.18%+103.6%
Operating Margin0.77%+102.3%
Net Margin3.17%+104.5%
ROE3%+104.8%
ROIC0.93%+102.5%
Debt/Equity0.01-44.3%

Technical→

DCTH Key Insights

Delcath Systems, Inc. (DCTH) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓FCF machine: 24.6% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 120.2%

✗Weaknesses

✗Shares diluted 40.0% in last year
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

DCTH Price & Volume

Delcath Systems, Inc. (DCTH) stock price & volume — 10-year historical chart

Loading chart...

DCTH Growth Metrics

Delcath Systems, Inc. (DCTH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years47.51%

5 Years120.21%

3 Years215.3%

TTM21.54%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM103.95%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM101.13%

Return on Capital

10 Years-2244.85%

5 Years-129.25%

3 Years-109.34%

Last Year0.72%

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
NVCRNovoCure LimitedDirect Competitor	1.92B	16.83	-13.80	8.28%	-25.66%	-50.82%	0.85
AGENAgenus Inc.Direct Competitor	132.45M	3.75	-1102.94	10.37%	0.1%
CLDXCelldex Therapeutics, Inc.Direct Competitor	2.22B	33.32	-8.54	-78.63%	-172.53%	-41.68%	0.00
IMVTImmunovant, Inc.Direct Competitor	5.53B	27.22	-9.97			-47.07%	0.00
HALOHalozyme Therapeutics, Inc.Product Competitor	7.68B	65.19	25.46	37.55%	22.69%	6.49%
INVAInnoviva, Inc.Product Competitor	1.93B	22.80	6.91	18.52%	118.91%	46.47%	0.23
TGTXTG Therapeutics, Inc.Product Competitor	6.87B	43.03	15.53	87.32%	65.95%	87.36%	0.40
RCUSArcus Biosciences, Inc.Product Competitor	2.5B	24.80	-7.54	-4.26%	-156.36%	-68.97%	0.16

Compare DCTH vs Peers

Delcath Systems, Inc. (DCTH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for DCTH.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare DCTH against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, AGEN, CLDX, IMVT

DCTH Income Statement

Delcath Systems, Inc. (DCTH) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	2.71M	3.41M	1.58M	1.65M	3.56M	2.72M	2.06M	37.2M	85.23M	65.45M
Revenue Growth %	36.3%	25.49%	-53.62%	4.18%	115.98%	-23.52%	-24.05%	1701.69%	129.08%	21.54%
Cost of Goods Sold	701K	1.01M	719K	640K	671K	686K	635K	6.19M	11.8M	8.95M
COGS % of Revenue	25.82%	29.62%	45.51%	38.88%	18.87%	25.23%	30.75%	16.63%	13.84%	-
Gross Profit	2.01M▲ 0%	2.4M▲ 19.1%	861K▼ 64.1%	1.01M▲ 16.8%	2.88M▲ 186.7%	2.03M▼ 29.5%	1.43M▼ 29.7%	31.02M▲ 2069.0%	73.43M▲ 136.8%	77.75M▲ 0%
Gross Margin %	74.18%	70.38%	54.49%	61.12%	81.13%	74.77%	69.25%	83.37%	86.16%	118.8%
Gross Profit Growth %	39.67%	19.07%	-64.1%	16.84%	186.68%	-29.51%	-29.66%	2069.02%	136.75%	-
Operating Expenses	20.18M	29.47M	20.77M	22.31M	27.41M	35.89M	39.61M	43.43M	72.77M	79.37M
OpEx % of Revenue	743.24%	864.95%	1314.49%	1355.35%	771.17%	1319.82%	1918.26%	116.72%	85.38%	-
Selling, General & Admin	9.68M	9.82M	11.28M	11.11M	13.64M	17.3M	22.11M	29.55M	43.53M	45.31M
SG&A % of Revenue	356.69%	288.2%	713.86%	674.85%	383.6%	636.37%	1070.7%	79.43%	51.07%	-
Research & Development	10.49M	19.65M	9.49M	11.2M	13.78M	18.58M	17.5M	13.87M	29.25M	34.06M
R&D % of Revenue	386.56%	576.75%	600.63%	680.5%	387.57%	683.45%	847.55%	37.29%	34.31%	-
Other Operating Expenses	-41K	51K	0	0	0	0	0	0	0	0
Operating Income	-18.16M▲ 0%	-27.07M▼ 49.0%	-19.91M▲ 26.5%	-21.3M▼ 7.0%	-24.53M▼ 15.2%	-33.85M▼ 38.0%	-38.18M▼ 12.8%	-12.41M▲ 67.5%	660K▲ 105.3%	-1.62M▲ 0%
Operating Margin %	-669.06%	-794.57%	-1260%	-1294.23%	-690.04%	-1245.05%	-1849.01%	-33.36%	0.77%	-2.47%
Operating Income Growth %	-10.49%	-49.03%	26.46%	-7.01%	-15.15%	-38%	-12.79%	67.5%	105.32%	-
EBITDA	-17.86M	-26.63M	-19.66M	-21.14M	-24.39M	-33.72M	-37.78M	-12.18M	1.01M	-1.39M
EBITDA Margin %	-657.64%	-781.54%	-1244.24%	-1284.08%	-685.94%	-1240.2%	-1829.69%	-32.74%	1.18%	-2.13%
EBITDA Growth %	-10.66%	-49.13%	26.17%	-7.51%	-15.37%	-38.29%	-12.05%	67.76%	108.28%	-12.54%
D&A (Non-Cash Add-back)	310K	444K	249K	167K	146K	132K	399K	229K	349K	228K
EBIT	-23.41M	-11.26M	-4.13M	-23.98M	-24.46M	-33.82M	-38.18M	-12.41M	3.51M	1.63M
Net Interest Income	-21.7M	-7.96M	-4.75M	-175K	-1.19M	-2.69M	-1.44M	0	2.92M	1.65M
Interest Income	0	0	0	0	0	0	0	0	2.92M	2.44M
Interest Expense	21.7M	7.96M	4.75M	175K	1.19M	2.69M	1.44M	0	0	0
Other Income/Expense	-26.95M	7.85M	11.03M	-2.85M	-1.12M	-2.65M	-9.5M	-13.98M	2.85M	2.96M
Pretax Income	-45.12M▲ 0%	-19.22M▲ 57.4%	-8.88M▲ 53.8%	-24.16M▼ 172.1%	-25.65M▼ 6.2%	-36.51M▼ 42.3%	-47.68M▼ 30.6%	-26.39M▲ 44.7%	3.51M▲ 113.3%	1.34M▲ 0%
Pretax Margin %	-1661.77%	-564.19%	-561.96%	-1467.56%	-721.49%	-1342.7%	-2308.86%	-70.92%	4.12%	2.04%
Income Tax	0	0	0	0	0	0	0	0	810K	777K
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	23.08%	58.07%
Net Income	-45.12M▲ 0%	-19.22M▲ 57.4%	-8.88M▲ 53.8%	-24.16M▼ 172.1%	-25.65M▼ 6.2%	-36.51M▼ 42.3%	-47.68M▼ 30.6%	-26.39M▲ 44.7%	2.7M▲ 110.2%	561K▲ 0%
Net Margin %	-1661.77%	-564.19%	-561.96%	-1467.56%	-721.49%	-1342.7%	-2308.86%	-70.92%	3.17%	0.86%
Net Income Growth %	-151.05%	57.4%	53.81%	-172.06%	-6.18%	-42.34%	-30.6%	44.66%	110.23%	103.95%
Net Income (Continuing)	-45.12M	-19.22M	-8.88M	-24.16M	-25.65M	-36.51M	-47.68M	-26.39M	2.7M	561K
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-999999.00▲ 0%	-503.85▲ 99.9%	-342.82▲ 32.0%	-8.35▲ 97.6%	-3.59▲ 57.0%	-4.12▼ 14.7%	-2.94▲ 28.7%	-0.93▲ 68.5%	0.07▲ 107.3%	0.02▲ 0%
EPS Growth %	99.83%	99.98%	31.96%	97.56%	57.04%	-14.74%	28.67%	68.5%	107.3%	101.13%
EPS (Basic)	-999999.00	-503.85	-342.82	-8.35	-3.59	-4.12	-2.94	-0.93	0.08	-
Diluted Shares Outstanding	20	38.15K	25.9K	2.9M	7.15M	8.86M	16.23M	28.51M	39.92M	36.02M
Basic Shares Outstanding	20	38.15K	25.9K	2.9M	7.15M	8.86M	16.23M	28.51M	35.82M	36.02M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

DCTH Balance Sheet

Delcath Systems, Inc. (DCTH) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	7.59M	5.92M	12.62M	32.34M	31.15M	16.16M	37.16M	73.76M	119.53M	120.27M
Cash & Short-Term Investments	4M	2.52M	10M	28.57M	22.8M	7.67M	32.45M	53.23M	91.04M	89.3M
Cash Only	4M	2.52M	10M	28.57M	22.8M	7.67M	12.65M	32.41M	43.45M	41.31M
Short-Term Investments	0	0	0	0	0	0	19.81M	20.82M	47.58M	47.99M
Accounts Receivable	317K	1.16M	21K	57K	44K	366K	483K	11.06M	11.74M	14.16M
Days Sales Outstanding	42.62	124.7	4.85	12.64	4.52	49.13	85.37	108.5	50.29	79.66
Inventory	1.25M	858K	654K	855K	1.41M	2M	3.32M	6.93M	10.25M	9.81M
Days Inventory Outstanding	649.81	310.38	332	487.62	768.08	1.06K	1.91K	408.94	317.2	421.27
Other Current Assets	1.47M	1.19M	626K	509K	4.36M	4.25M	387K	1.39M	6.5M	7M
Total Non-Current Assets	1.3M	925K	1.59M	2.3M	1.97M	1.71M	1.46M	2.83M	4.1M	4.57M
Property, Plant & Equipment	1.3M	925K	1.59M	2.3M	1.97M	1.71M	1.46M	2.83M	4.1M	4.57M
Fixed Asset Turnover	2.09x	3.68x	0.99x	0.72x	1.80x	1.59x	1.42x	13.15x	20.78x	16.63x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	0
Total Assets	8.89M▲ 0%	6.84M▼ 23.0%	14.21M▲ 107.7%	34.63M▲ 143.7%	33.12M▼ 4.4%	17.86M▼ 46.1%	38.61M▲ 116.2%	76.59M▲ 98.4%	123.63M▲ 61.4%	124.84M▲ 0%
Asset Turnover	0.31x	0.50x	0.11x	0.05x	0.11x	0.15x	0.05x	0.49x	0.69x	0.53x
Asset Growth %	-74.78%	-22.99%	107.66%	143.7%	-4.36%	-46.08%	116.17%	98.35%	61.42%	641.36%
Total Current Liabilities	7.81M	17.75M	15.99M	10.04M	5.95M	14.73M	16.45M	6.14M	10.95M	10.7M
Accounts Payable	3.85M	7.71M	4.53M	1.77M	638K	2.02M	1.01M	961K	2.66M	3.46M
Days Payables Outstanding	2K	2.79K	2.3K	1.01K	347.05	1.07K	581.7	56.68	82.24	132.21
Short-Term Debt	0	2.04M	0	2M	621K	7.85M	10.15M	0	0	92K
Deferred Revenue (Current)	0	3.4M	482K	525K	170K	0	0	0	0	0
Other Current Liabilities	2.84M	6.21M	9.39M	4.3M	2.41M	1.04M	1.93M	3.71M	8.19M	7.14M
Current Ratio	0.97x	0.33x	0.79x	3.22x	5.23x	1.10x	2.26x	12.01x	10.92x	10.92x
Quick Ratio	0.81x	0.29x	0.75x	3.14x	4.99x	0.96x	2.06x	10.88x	9.98x	9.98x
Cash Conversion Cycle	-1.31K	-2.36K	-1.96K	-511.48	425.55	38.49	1.41K	460.76	285.25	368.72
Total Non-Current Liabilities	395K	4.03M	4.58M	2.52M	15.22M	8.99M	6.39M	1.7M	1.46M	1.43M
Long-Term Debt	0	0	2M	0	15.01M	7.84M	0	0	0	815K
Capital Lease Obligations	0	0	197K	450K	207K	0	0	933K	835K	2.57M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	395K	628K	0	0	0	1.14M	6.39M	766K	628K	2.4M
Total Liabilities	8.21M	21.78M	20.57M	12.56M	21.17M	23.72M	22.84M	7.84M	12.41M	12.13M
Total Debt	0	2.04M	2.86M	2.94M	16.25M	15.87M	10.19M	1.04M	936K	907K
Net Debt	-4M	-478K	-7.14M	-25.63M	-6.55M	8.2M	-2.46M	-31.37M	-42.52M	-40.41M
Debt / Equity	-	-	-	0.13x	1.36x	-	0.65x	0.02x	0.01x	0.01x
Debt / EBITDA	-	-	-	-	-	-	-	-	0.93x	-0.65x
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-42.14x	-42.14x
Interest Coverage	-1.08x	-1.42x	-0.87x	-137.03x	-20.63x	-12.60x	-26.53x	-	-	-
Total Equity	678K▲ 0%	-14.94M▼ 2303.4%	-6.36M▲ 57.4%	22.08M▲ 447.3%	11.95M▼ 45.9%	-5.86M▼ 149.0%	15.78M▲ 369.3%	68.75M▲ 335.7%	111.22M▲ 61.8%	112.71M▲ 0%
Equity Growth %	145.5%	-2303.39%	57.45%	447.3%	-45.86%	-149.02%	369.28%	335.74%	61.78%	3746.65%
Book Value per Share	33772.94	-391.59	-245.44	7.62	1.67	-0.66	0.97	2.41	2.79	3.13
Total Shareholders' Equity	678K	-14.94M	-6.36M	22.08M	11.95M	-5.86M	15.78M	68.75M	111.22M	112.71M
Common Stock	1.14M	103K	1K	60K	79K	100K	228K	331K	347K	344K
Retained Earnings	-324.83M	-344.05M	-371.17M	-395.33M	-420.98M	-457.48M	-505.16M	-531.55M	-528.85M	-529.92M
Treasury Stock	-51K	0	0	0	0	0	0	0	0	0
Accumulated OCI	42K	50K	28K	-104K	18K	-83K	135K	82K	575K	571K
Minority Interest	0	0	0	0	0	0	0	0	0	0

DCTH Cash Flow Statement

Delcath Systems, Inc. (DCTH) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	-15.4M	-14.73M	-23.69M	-22.87M	-22.6M	-24.95M	-31.25M	-18.68M	22.52M	22.52M
Operating CF Margin %	-567.15%	-432.4%	-1499.3%	-1389.31%	-635.84%	-917.62%	-1513.37%	-50.21%	26.42%	-
Operating CF Growth %	-8.34%	4.33%	-60.8%	3.47%	1.15%	-10.38%	-25.25%	40.22%	220.53%	1353.73%
Net Income	-45.12M	-19.22M	-8.88M	-24.16M	-25.65M	-36.51M	-47.68M	-26.39M	2.7M	561K
Depreciation & Amortization	310K	444K	249K	192K	146K	132K	128K	229K	349K	413K
Stock-Based Compensation	129K	58K	277K	3.91M	7.83M	7.94M	8.15M	9.77M	24.23M	16.67M
Deferred Taxes	5.23M	-15.76M	0	2.83M	0	0	0	0	0	0
Other Non-Cash Items	21.54M	7.97M	-9.77M	159K	831K	1.37M	9.05M	13.23M	-1.7M	1.11M
Working Capital Changes	2.51M	11.77M	-5.56M	-5.81M	-5.76M	2.11M	-906K	-15.52M	-3.07M	2.42M
Change in Receivables	108K	-293K	497K	-36K	13K	-322K	125K	-10.65M	-854K	-217K
Change in Inventory	-543K	385K	204K	-201K	-557K	-587K	-1.32M	-3.61M	-3.32M	-2.68M
Change in Payables	3.18M	8.18M	-4.79M	-5.31M	-1.14M	1.8M	-199K	479K	4.77M	5.42M
Cash from Investing	-524K	-76K	-24K	-782K	-143K	-209K	-19.71M	-981K	-26.59M	-2.01M
Capital Expenditures	-524K	-76K	-24K	-782K	-143K	-209K	-58K	-559K	-1.55M	-1.98M
CapEx % of Revenue	19.3%	2.23%	1.52%	47.51%	4.02%	7.69%	2.81%	1.5%	1.82%	-
Acquisitions	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0
Cash from Financing	15.45M	13.24M	30.3M	42.35M	20.82M	10.14M	51.78M	39.41M	15.05M	9.41M
Debt Issued (Net)	0	794K	3.68M	-26K	14.44M	-714K	-6.31M	-10.61M	0	0
Equity Issued (Net)	0	0	26.63M	39.76M	3.92M	10.86M	23.08M	7.02M	15.05M	11.79M
Dividends Paid	-527K	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	-6M	-5.61M
Other Financing	2.85M	12.44M	0	2.62M	2.46M	0	35.01M	43M	0	-2.38M
Net Change in Cash	-410K▲ 0%	-1.75M▼ 325.9%	6.61M▲ 478.4%	18.57M▲ 181.2%	-1.8M▼ 109.7%	-15.13M▼ 739.2%	874K▲ 105.8%	19.72M▲ 2155.8%	11.04M▼ 44.0%	28.54M▲ 0%
Free Cash Flow	-15.92M▲ 0%	-14.81M▲ 7.0%	-23.71M▼ 60.1%	-23.65M▲ 0.3%	-22.75M▲ 3.8%	-25.16M▼ 10.6%	-31.31M▼ 24.4%	-19.24M▲ 38.5%	20.97M▲ 209.0%	19.19M▲ 0%
FCF Margin %	-586.45%	-434.63%	-1500.82%	-1436.82%	-639.86%	-925.3%	-1516.17%	-51.71%	24.6%	29.33%
FCF Growth %	-10.03%	7%	-60.14%	0.27%	3.82%	-10.6%	-24.44%	38.55%	208.99%	353.21%
FCF per Share	-793116.15	-388.15	-915.56	-8.16	-3.18	-2.84	-1.93	-0.67	0.53	0.53
FCF Conversion (FCF/Net Income)	0.34x	0.77x	2.67x	0.95x	0.88x	0.68x	0.66x	0.71x	8.34x	34.21x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

DCTH Key Ratios

Delcath Systems, Inc. (DCTH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-6654.42%	-	-	-307.31%	-150.74%	-1198.36%	-961.44%	-62.44%	3%	0.51%
Return on Invested Capital (ROIC)	-660.87%	-	-	-	-1985.78%	-655.3%	-365.68%	-36.72%	0.93%	0.93%
Gross Margin	74.18%	70.38%	54.49%	61.12%	81.13%	74.77%	69.25%	83.37%	86.16%	118.8%
Net Margin	-1661.77%	-564.19%	-561.96%	-1467.56%	-721.49%	-1342.7%	-2308.86%	-70.92%	3.17%	0.86%
Debt / Equity	-	-	-	0.13x	1.36x	-	0.65x	0.02x	0.01x	0.01x
Interest Coverage	-1.08x	-1.42x	-0.87x	-137.03x	-20.63x	-12.60x	-26.53x	-	-	-
FCF Conversion	0.34x	0.77x	2.67x	0.95x	0.88x	0.68x	0.66x	0.71x	8.34x	34.21x
Revenue Growth	36.3%	25.49%	-53.62%	4.18%	115.98%	-23.52%	-24.05%	1701.69%	129.08%	21.54%

DCTH SEC Filings & Documents

Delcath Systems, Inc. (DCTH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 7, 2026·SEC

Material company update

Mar 3, 2026·SEC

Material company update

Feb 26, 2026·SEC

10-K Annual Reports

FY 2026

Feb 26, 2026·SEC

FY 2025

Mar 6, 2025·SEC

FY 2024

Mar 26, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 7, 2026·SEC

FY 2025

Nov 4, 2025·SEC

FY 2025

Aug 6, 2025·SEC

DCTH Frequently Asked Questions

Delcath Systems, Inc. (DCTH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Delcath Systems, Inc. (DCTH) reported $65.4M in revenue for fiscal year 2025.

Delcath Systems, Inc. (DCTH) grew revenue by 129.1% over the past year. This is strong growth.

Yes, Delcath Systems, Inc. (DCTH) is profitable, generating $0.6M in net income for fiscal year 2025 (3.2% net margin).

Dividend & Returns

Delcath Systems, Inc. (DCTH) has a return on equity (ROE) of 3.0%. This is below average, suggesting room for improvement.

Delcath Systems, Inc. (DCTH) generated $19.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More DCTH

Delcath Systems, Inc. (DCTH) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Delcath Systems, Inc.(DCTH)Earnings, Financials & Key Ratios

DCTH Key Insights

✓Strengths

✗Weaknesses

DCTH Price & Volume

DCTH Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

DCTH Peer Comparison

Compare DCTH vs Peers

vs NVCR

vs ISRG

Compare Top 5

DCTH Income Statement

DCTH Balance Sheet

DCTH Cash Flow Statement

DCTH Key Ratios

DCTH SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

DCTH Frequently Asked Questions

Explore More DCTH

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation